NDC 51672-4119 - Nortriptyline Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-4119
- Package NDCs from labels
- 51672-4119-9
- Manufacturer
- Taro Pharmaceuticals U.S.A., Inc.
- Effective date
- 2008-11-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Nortriptyline Hydrochloride Oral Solution, USP | Taro Pharmaceuticals U.S.A., Inc. | 2008-11-04 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-4119-9 | Nortriptyline Hydrochloride | 473 mL in 1 BOTTLE | SOLUTION | 473 | 1 | |
| 51672-4119-9 | Nortriptyline Hydrochloride | 1 in 1 CARTON | SOLUTION | 1 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-4119 | NORTRIPTYLINE HYDROCHLORIDE SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 1 | 2 package rows | 20090320_C1DFE613-D8AC-4F18-9AAF-5F11044DE2B1.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Nortriptyline Hydrochloride | ACTIVE INGREDIENT | 00FN6IH15D | NORTRIPTYLINE HYDROCHLORIDE SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 1 | |
| Nortriptyline | ACTIVE MOIETY | BL03SY4LXB | NORTRIPTYLINE HYDROCHLORIDE SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 1 | |
| alcohol | INACTIVE INGREDIENT | 3K9958V90M | NORTRIPTYLINE HYDROCHLORIDE SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 1 | |
| benzoic acid | INACTIVE INGREDIENT | 8SKN0B0MIM | NORTRIPTYLINE HYDROCHLORIDE SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 1 | |
| cherry flavor (artificial) | INACTIVE INGREDIENT | NORTRIPTYLINE HYDROCHLORIDE SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 1 | ||
| sorbitol | INACTIVE INGREDIENT | 506T60A25R | NORTRIPTYLINE HYDROCHLORIDE SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 1 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | NORTRIPTYLINE HYDROCHLORIDE SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | PAI Holdings, LLC dba PAI Pharma | 3fcabf90-357a-4a06-b680-9572dc28bcfe | 2026-01-26 | Boxed warning, Warnings, Adverse reactions | 312036 |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | Advagen Pharma Ltd | bef9e24d-e730-4801-ab25-75e7d6bde225 | 2026-01-07 | Boxed warning, Warnings, Adverse reactions | 312036 |
| 094D8D59-7520-2EDD-6559-9FFE46AD633A | C1DFE613-D8AC-4F18-9AAF-5F11044DE2B1 | 2008-11-04 | Boxed warning, Warnings, Adverse reactions | 094D8D59-7520-2EDD-6559-9FFE46AD633A C1DFE613-D8AC-4F18-9AAF-5F11044DE2B1 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.